GlassScriptPhysician profile
Steven A Snipes
NPI 1689669210
$14,404.81
in general payments reported to CMS, 2019-2025
40 companies · $2,569 in 2025
The $2,569 reported for 2025 was more than what 97% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,276 · 2022: $2,672 · 2023: $3,408 · 2024: $3,480 · 2025: $2,569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,946 · Education: $283 · Travel and Lodging: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,946.03 |
| Education | $282.54 |
| Travel and Lodging | $228.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,861.37 | 2021-2025 | Interstim, Altaviva |
| Dendreon Pharmaceuticals LLC | $1,269.03 | 2021-2025 | Provenge |
| Sumitomo Pharma America, INC. | $1,129.21 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $1,122.82 | 2023-2025 | Urolift, Barrigel |
| Axonics, INC. | $997.90 | 2021-2024 | Axonics |
| Astellas Pharma US INC | $957.08 | 2021-2025 | Veozah, Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $783.68 | 2021-2025 | |
| Pfizer INC. | $749.77 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $712.26 | 2023-2025 | Prolaris |
| Urogen Pharma, INC. | $574.73 | 2021-2025 | |
| Accord Healthcare, INC. | $568.75 | 2024-2025 | |
| Antares Pharma, INC. | $505.98 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Janssen Biotech, INC. | $504.98 | 2021-2025 | Erleada, Akeega, Balversa |
| Merck Sharp & Dohme LLC | $333.00 | 2022-2024 | Keytruda, Lynparza, Welireg |
| Myovant Sciences INC. | $304.02 | 2021-2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $276.08 | 2021-2024 | Lynparza |
| Urovant Sciences INC | $251.55 | 2021-2022 | |
| Abbvie INC. | $228.83 | 2021-2025 | |
| Endo Pharmaceuticals INC. | $225.21 | 2021-2023 | Aveed, Xiaflex |
| Boston Scientific Corporation | $216.44 | 2021-2025 | Rezum Generator, Axonics, Ams 700 |
| Endo USA, INC. | $104.85 | 2024-2025 | Xiaflex, Aveed |
| 180 Medical, INC. | $103.19 | 2021-2023 | Gentlecath Glide |
| Halozyme INC | $83.38 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $74.80 | 2022 | |
| Sun Pharmaceutical Industries INC. | $65.83 | 2021-2023 | Yonsa |
| Amgen INC. | $65.59 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $53.09 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $36.77 | 2025 | Tlando |
| Allergan, INC. | $34.03 | 2021 | |
| Janssen Pharmaceuticals, INC | $31.61 | 2022 | |
| Immunitybio, INC. | $24.95 | 2025 | |
| Novartis Pharmaceuticals Corporation | $23.21 | 2025 | |
| Novo Nordisk INC | $20.41 | 2025 | Wegovy |
| Telix Pharmaceuticals | $18.90 | 2025 | Illuccix |
| Calyxo, INC. | $17.42 | 2025 | Cvac Aspiration System |
| Blue Earth Diagnostics | $16.55 | 2021 | |
| Lilly USA, LLC | $15.80 | 2024 | Zepbound |
| Tolmar, INC. | $14.98 | 2024 | |
| Acerus Pharmaceuticals Corporation | $13.66 | 2022 | |
| Laborie Medical Technologies Corp. | $13.10 | 2024 | Urgent PC Neuromodulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Snipes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.